Skandinaviska Enskilda Banken (SEB)’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-18,223
| Closed | -$555K | – | 900 |
|
|
2023
Q4 | $555K | Hold |
18,223
| – | – | ﹤0.01% | 769 |
|
|
2023
Q3 | $576K | Hold |
18,223
| – | – | ﹤0.01% | 746 |
|
|
2023
Q2 | $743K | Buy |
18,223
+3,211
| +21% | +$131K | ﹤0.01% | 742 |
|
|
2023
Q1 | $559K | Sell |
15,012
-688
| -4% | -$25.6K | ﹤0.01% | 767 |
|
|
2022
Q4 | $548K | Sell |
15,700
-909
| -5% | -$31.7K | ﹤0.01% | 724 |
|
|
2022
Q3 | $929K | Buy |
16,609
+4,327
| +35% | +$242K | 0.01% | 695 |
|
|
2022
Q2 | $636K | Hold |
12,282
| – | – | ﹤0.01% | 776 |
|
|
2022
Q1 | $893K | Hold |
12,282
| – | – | 0.01% | 766 |
|
|
2021
Q4 | $1.49M | Sell |
12,282
-75
| -0.6% | -$9.09K | 0.01% | 711 |
|
|
2021
Q3 | $1.66M | Buy |
+12,357
| New | +$1.66M | 0.01% | 698 |
|
|
2021
Q1 | – | Sell |
-39,935
| Closed | -$2.17M | – | 1176 |
|
|
2020
Q4 | $2.17M | Buy |
39,935
+364
| +0.9% | +$19.8K | 0.01% | 622 |
|
|
2020
Q3 | $787K | Buy |
39,571
+38,678
| +4,331% | +$769K | 0.01% | 776 |
|
|
2020
Q2 | $19K | Buy |
+893
| New | +$19K | ﹤0.01% | 1020 |
|